Azione FRX FENNEC PHARMACEUTICALS INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Fennec Pharmaceuticals Inc. Toronto S.E.

Azioni

FRX

CA31447P1009

Mercato chiuso - Toronto S.E.
Altri mercati azionari
 21:59:59 17/07/2024 		Variaz. 5gg Var. 1 gen.
9,1 CAD -0,55% Grafico intraday di Fennec Pharmaceuticals Inc. +12,62% -39,97%
02/07 MT Newswires Azioni da tenere d'occhio nel fine settimana: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris MT
01/07 Fennec Pharmaceuticals Inc. annuncia cambiamenti esecutivi CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc. Announces Executive Changes
Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals : Corporate Presentation May 2024
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue
Fennec Pharmaceuticals Brief: Company Says Has Approximately US$51 Million in Cash, Cash Equivalents, and Investment Securities
Fennec Pharmaceuticals Brief: Achieved Q1 2024 Total Net Revenues of US$25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing
Fennec Pharmaceuticals : Corporate Presentation March 2024
Wedbush on Fennec's Q4
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione FENC
  4. Azione FRX
  5. Notizie Fennec Pharmaceuticals Inc.
  6. Altre lingue